201 related articles for article (PubMed ID: 4164172)
1. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
Egami T
Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
[No Abstract] [Full Text] [Related]
2. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
Santo K
Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
[No Abstract] [Full Text] [Related]
3. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children.
Black FL; Gudnadóttir M
Bull World Health Organ; 1966; 35(6):955-7. PubMed ID: 4165239
[No Abstract] [Full Text] [Related]
4. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
[No Abstract] [Full Text] [Related]
5. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
[No Abstract] [Full Text] [Related]
6. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
[No Abstract] [Full Text] [Related]
7. Observation of the protective effect of live measles vaccines in the first year after vaccination.
Sejda J; Helcl J; Strauss J
J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
[No Abstract] [Full Text] [Related]
8. Use of two live measles vaccines in virgin populations in arctic Greenland. Clinical and serological reactions in children and adults.
Mordhorst CH; Tulinius S; von Magnus H
Dan Med Bull; 1968 Nov; 15(9):263-70. PubMed ID: 4102838
[No Abstract] [Full Text] [Related]
9. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
10. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
Sekiguchi H; Numazaki Y; Ikeda M; Yano N
Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
[No Abstract] [Full Text] [Related]
11. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
12. CONTROLLED TRIAL OF LIVE MEASLES VACCINE. EFFECTS OF AGE, HISTORY OF MEASLES IN SIBLINGS, PREVACCINE ANTIBODY, AND HUMAN GAMMA-GLOBULIN ON SYMPTOMATIC AND IMMUNE RESPONSES.
MARTIN CM; MANFREDONIA SJ; WEBB NC; MARKHAM FS; RUEGSEGGER JM
Am J Dis Child; 1963 Sep; 106():267-79. PubMed ID: 14057606
[No Abstract] [Full Text] [Related]
13. [Clinical and immunoserological studies of measles vaccine inoculation].
Ichinomiya K
Nihon Shonika Gakkai Zasshi; 1968 Jul; 72(7):875-86. PubMed ID: 4178508
[No Abstract] [Full Text] [Related]
14. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
[No Abstract] [Full Text] [Related]
15. [Activities of immune globulins at the time of measles vaccine inoculation and measles infection, with special reference to sensitivity and resistance of the antibody to 2-mercaptoethanol].
Arai M; Nakamura M
Nihon Shonika Gakkai Zasshi; 1969 Dec; 73(12):2032-7. PubMed ID: 4191839
[No Abstract] [Full Text] [Related]
16. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
Boué A; Celers J
Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
[No Abstract] [Full Text] [Related]
17. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
[No Abstract] [Full Text] [Related]
18. Clinical and serological evaluation of live measles vaccine in India.
Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
[No Abstract] [Full Text] [Related]
19. The development and the study of live measles vaccine from highly attenuated strain Enders-Schwarz-Chumakov (ESC).
Chumakov MP; Voroshilova MK; Grachev VP; Dzagurov SG; Sinyak KM
Prog Immunobiol Stand; 1967; 3():194-5. PubMed ID: 5379939
[No Abstract] [Full Text] [Related]
20. [Trials of vaccination against measles with live and attenuated virus].
Albano A; De Donato S; Nodari R; Criscuolo A
G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
